Bullish option flow detected in Crispr Therapeutics (CRSP) with 6,908 calls trading, 3x expected, and implied vol increasing almost 4 points to 63.88%. 6/6 weekly 40 calls and Jun-25 40 calls are the most active options, with total volume in those strikes near 1,900 contracts. The Put/Call Ratio is 0.14. Earnings are expected on August 5th.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Promising Growth and Diversification Drive Buy Rating for Crispr Therapeutics AG
- Cathie Wood’s ARK Investment buys 294K shares of Crispr Therapeutics today
- Cathie Wood Doubles Down on Nvidia Stock (NVDA) Ahead of Q1 Earnings
- Cathie Wood’s ARK Investment buys 262K shares of Crispr Therapeutics today
- Crispr Therapeutics AG: Promising Partnership with Sirius Therapeutics Amidst Clinical and Market Uncertainties Warrants Hold Rating